SCHEMBL16644758

SCHEMBL16644758

C[C@@H]1O[C@@H](OCCNC(=O)CN(CC(=O)NCCCCCC(=O)Nc2ccccc2)CC(=O)NCCO[C@H]2O[C@H](CO[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H](O)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]3O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MMP13 P45452 2/20 0.47
▸ FGF1 P05230 2/20 0.41
▸ FGF2 P09038 2/20 0.41
▸ VEGFA P15692 2/20 0.41
▸ HPSE Q9Y251 2/20 0.41
▸ ALDH1A1 P00352 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ MAPK1 P28482 1/20 0.41
▸ HSD17B10 Q99714 1/20 0.41
▸ CD209 Q9NNX6 2/20 0.40
▸ SELP P16109 1/20 0.39
▸ HDAC3 O15379 5/20 0.38
▸ HDAC4 P56524 5/20 0.38
▸ HDAC1 Q13547 5/20 0.38
▸ HDAC7 Q8WUI4 5/20 0.38
▸ HDAC2 Q92769 5/20 0.38
▸ HDAC10 Q969S8 5/20 0.38
▸ HDAC11 Q96DB2 5/20 0.38
▸ HDAC8 Q9BY41 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16509354 0.93 MMP13 (0.48) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL18056168 0.92 MMP13 (0.42) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL18164150 0.92 MMP13 (0.42) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL30891378 0.89 MMP13 (0.46) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL19860816 0.89 MMP13 (0.46) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL16628168 0.89 MMP13 (0.46) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL18164176 0.89 MMP13 (0.47) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL16640842 0.89 MMP13 (0.47) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL16640802 0.89 MMP13 (0.47) MMP13FGF1FGF2VEGFAHPSE
SCHEMBL16640798 0.89 MMP13 (0.47) MMP13FGF1FGF2VEGFAHPSE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160303244-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES MERCK SHARP & DOHME CORP. (US) 2016-10-20 — — US disclosed
US-9427475-B2 Glucose-responsive insulin conjugates MERCK SHARP & DOHME CORP. (US) 2016-08-30 — — US disclosed
US-20150105317-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES MERCK SHARP & DOHME LLC 2015-04-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150105317-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES GPR119, INSR, IRS1 MMP13 3215/4885FGF1 611/4885FGF2 462/4885
US-20160303244-A1 GLUCOSE-RESPONSIVE INSULIN CONJUGATES GPR119, INSR, IRS1 MMP13 3215/4885FGF1 611/4885FGF2 462/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback